[1]
“A pilot study about subcutaneous administration of 10% immunoglobulin in patients with primary immune deficiencies: Single center experience ”, Ann Med Res , vol. 24, no. 4, pp. 0457–0461, May 2021, Accessed: Apr. 04, 2025. [Online]. Available: http://annalsmedres.org/index.php/aomr/article/view/1580